Journal of Experimental Pharmacology,
Год журнала:
2020,
Номер
Volume 12, С. 285 - 300
Опубликована: Авг. 1, 2020
Viloxazine
was
historically
described
as
a
norepinephrine
reuptake
inhibitor
(NRI).
Since
NRIs
have
previously
demonstrated
efficacy
in
attention
deficit/hyperactivity
disorder
(ADHD),
viloxazine
underwent
contemporary
investigation
the
treatment
of
ADHD.
Its
clinical
and
safety
profile,
however,
found
to
be
distinct
from
other
ADHD
medications
targeting
reuptake.
Considering
complexity
neuropsychiatric
disorders,
understanding
mechanism
action
(MoA)
is
an
important
differentiating
point
between
provides
pharmacology-based
rationale
for
physicians
prescribing
appropriate
therapy.Viloxazine
evaluated
series
vitro
binding
functional
assays.
effect
on
neurotransmitter
levels
brain
using
microdialysis
freely
moving
rats.We
report
effects
serotoninergic
(5-HT)
system.
In
vitro,
antagonistic
activity
at
5-HT2B
agonistic
5-HT2C
receptors,
along
with
predicted
high
receptor
occupancy
doses.
vivo,
increased
extracellular
5-HT
prefrontal
cortex
(PFC),
area
implicated
also
exhibited
moderate
inhibitory
transporter
(NET)
elicited
noradrenergic
dopaminergic
systems.Viloxazine's
ability
increase
PFC
its
certain
subtypes,
which
were
shown
suppress
hyperlocomotion
animals,
indicate
that
modulating
(if
not
predominant)
component
MoA,
complemented
by
NET
inhibition.
Supported
data,
these
findings
suggest
updated
psychopharmacological
profile
can
best
explained
serotonin
agent
(SNMA).
Frontiers in Neural Circuits,
Год журнала:
2021,
Номер
15
Опубликована: Июнь 7, 2021
The
locus
coeruleus
(LC),
a
small
brainstem
nucleus,
is
the
primary
source
of
neuromodulator
norepinephrine
(NE)
in
brain.
LC
receives
input
from
widespread
brain
regions,
and
projects
throughout
forebrain,
brainstem,
cerebellum,
spinal
cord.
neurons
release
NE
to
control
arousal,
but
also
context
variety
sensory-motor
behavioral
functions.
Despite
its
brain-wide
effects,
much
about
role
LC-NE
behavior
circuits
controlling
activity
unknown.
New
evidence
suggests
that
modular
input-output
organization
could
enable
transient,
task-specific
modulation
distinct
regions.
Future
work
must
further
assess
whether
this
spatial
modularity
coincides
with
functional
differences
subpopulations
acting
at
specific
times,
how
such
spatiotemporal
specificity
might
influence
learned
behaviors.
Here,
we
summarize
state
field
present
new
ideas
on
Current Biology,
Год журнала:
2018,
Номер
28(6), С. 859 - 871.e5
Опубликована: Март 1, 2018
Defensive
responses
to
threatening
stimuli
are
crucial
the
survival
of
species.
While
expression
these
is
considered
be
instinctive
and
unconditional,
their
magnitude
may
affected
by
environmental
internal
factors.
The
neural
circuits
underlying
this
modulation
still
largely
unknown.
In
mice,
looming-evoked
defensive
mediated
superior
colliculus
(SC),
a
subcortical
sensorimotor
integration
center.
We
found
that
repeated
stress
caused
an
anxiety-like
state
in
mice
accelerated
looming.
Stress
also
induced
c-fos
activation
locus
coeruleus
(LC)
tyrosine
hydroxylase
(TH)+
neurons
modified
adrenergic
receptor
SC,
suggesting
possible
Th::LC-SC
projection
involved
responses.
Indeed,
both
anterograde
retrograde
tracing
confirmed
anatomical
SC-projecting
TH+
LC
were
activated
stress.
Optogenetic
stimulation
either
or
fibers
behaviors
Meanwhile,
chemogenetic
inhibition
infusion
antagonist
SC
abolished
enhanced
looming
after
stress,
confirming
necessity
pathway.
These
findings
suggest
pathway
plays
key
role
sophisticated
adjustments
changes
physiological
states.
Frontiers in Pharmacology,
Год журнала:
2020,
Номер
11
Опубликована: Апрель 8, 2020
Nowadays
it
is
well
accepted
that
in
Parkinson’s
disease
(PD),
the
neurodegenerative
process
occurs
stages
and
damage
to
other
areas
precedes
neuronal
loss
substantia
nigra
pars
compacta,
which
considered
a
pathophysiological
hallmark
of
PD.
This
heterogeneous
progressive
neurodegeneration
may
explain
diverse
symptomatology
disease,
including
motor
non-motor
alterations.
In
PD,
one
first
undergoing
degeneration
locus
coeruleus
(LC).
noradrenergic
nucleus
provides
extensive
innervation
throughout
brain
plays
fundamental
neuromodulator
role,
participating
stress
responses,
emotional
memory
control
motor,
sensory
autonomic
functions.
Early
LC
neurons
suffer
modifications
can
condition
effectiveness
pharmacological
treatments,
importantly,
lead
appearance
common
symptomatology.
The
system
also
exerts
anti-inflammatory
neuroprotective
effect
on
dopaminergic
consequently
progress
disease.
From
point
view,
important
understand
how
performs
since
medication
often
used
these
patients,
drug
interactions
take
place
when
combining
them
with
gold
standard
therapy
L-DOPA.
review
an
overview
about
functional
status
PD
its
contribution
efficacy
pharmacological-based
treatments.
Based
preclinical
clinical
publications,
special
attention
will
be
dedicated
most
prevalent
symptoms
Cell Reports,
Год журнала:
2018,
Номер
23(8), С. 2225 - 2235
Опубликована: Май 1, 2018
Preclinical
work
has
long
focused
on
male
animals,
though
biological
sex
clearly
influences
risk
for
certain
diseases,
including
many
psychiatric
disorders.
Such
disorders
are
often
treated
by
drugs
targeting
the
CNS
norepinephrine
system.
Despite
roles
noradrenergic
neurons
in
behavior
and
neuropsychiatric
disease
models,
their
molecular
characterization
lagged.
We
profiled
mouse
vivo,
defining
over
3,000
high-confidence
transcripts
expressed
therein,
druggable
receptors.
uncovered
remarkable
differences
gene
expression,
elevated
expression
of
EP3
receptor
females—which
we
leverage
to
illustrate
behavioral
pharmacologic
relevance
these
findings—and
Slc6a15
Lin28b,
both
major
depressive
disorder
(MDD)-associated
genes.
Broadly,
present
a
means
transcriptionally
profiling
locus
coeruleus
under
baseline
experimental
conditions.
Our
findings
underscore
need
preclinical
include
sexes
suggest
that
may
underlie
relevant
disease.
Neuron,
Год журнала:
2019,
Номер
103(3), С. 489 - 505.e7
Опубликована: Июнь 13, 2019
Highlights•Fear
learning
selectively
engages
the
anatomically
distinct
DRN→BA
5-HT
pathway•The
pathway
bidirectionally
modulates
fear
and
extinction•The
sculpts
fear-associated
neuronal
activity
in
BA•The
expresses
VGluT3
but
drives
via
BA
5-HT1A/2A
receptorsSummaryDespite
a
wealth
of
clinical
preclinical
data
implicating
serotonin
(5-HT)
system
fear-related
affective
disorders,
precise
definition
this
neuromodulator's
role
remains
elusive.
Using
convergent
anatomical
functional
approaches,
we
interrogate
contribution
to
basal
amygdala
(BA)
inputs
from
dorsal
raphe
nucleus
(DRN).
We
show
is
engaged
during
memory
formation
retrieval,
these
projections
facilitates
impairs
extinction.
The
amplifies
firing
theta
power
phase-locking.
Although
recruits
co-expressing
DRN
neurons,
fear-potentiating
influence
requires
signaling
at
receptors.
Input-output
mapping
illustrates
how
connected
with
other
brain
regions
that
mediate
fear.
These
findings
reveal
discrete
circuit
orchestrates
broader
neural
network
calibrate
aversive
memory.Graphical
abstract